2024 Annual Meeting | C162 - Health Equity for Neurologists
Program Materials Program Evaluations
01:10 PM - 01:40 PM MDT | Speaker |
Global Health Equity in Neurology
Farrah J. Mateen, MD, PhD, FAAN |
01:40 PM - 02:10 PM MDT | Speaker |
Overlooked Disparities: A Report from the Trenches
Karen L. Skjei, MD |
02:10 PM - 02:40 PM MDT | Speaker |
Health Equity Education for Neurologists
Jillian M. Berkman, MD |
Farrah J. Mateen, MD, PhD, FAAN | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics. |
Jillian M. Berkman, MD | Dr. Berkman has received personal compensation in the range of $0-$499 for serving as a Consultant for Medzown. Dr. Berkman has stock in Medzown. |
Karen L. Skjei, MD | Dr. Skjei has nothing to disclose. |